Becton, Dickinson and Company Stock Sao Paulo

Equities

B1DX34

BRB1DXBDR008

Medical Equipment, Supplies & Distribution

Market Closed - Sao Paulo 09:27:40 2024-05-28 am EDT 5-day change 1st Jan Change
233.3 BRL -3.19% Intraday chart for Becton, Dickinson and Company -.--% +2.04%
Sales 2024 * 20.25B 108B Sales 2025 * 21.43B 115B Capitalization 67.04B 359B
Net income 2024 * 2.09B 11.21B Net income 2025 * 2.48B 13.27B EV / Sales 2024 * 3.96 x
Net Debt 2024 * 13.13B 70.3B Net Debt 2025 * 10.8B 57.8B EV / Sales 2025 * 3.63 x
P/E ratio 2024 *
32.6 x
P/E ratio 2025 *
28.8 x
Employees 73,000
Yield 2024 *
1.62%
Yield 2025 *
1.66%
Free-Float 77.74%
More Fundamentals * Assessed data
Dynamic Chart
1 day-3.19%
1 month-3.40%
3 months-0.47%
6 months+2.04%
Current year+2.04%
More quotes
1 month
233.28
Extreme 233.28
241.20
Current year
231.63
Extreme 231.63
244.56
1 year
214.70
Extreme 214.7
272.01
3 years
214.70
Extreme 214.7
295.00
5 years
213.30
Extreme 213.3
295.00
10 years
213.30
Extreme 213.3
295.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 08-12-31
Director of Finance/CFO 52 21-09-05
Chief Tech/Sci/R&D Officer 48 18-12-31
Members of the board TitleAgeSince
Director/Board Member 73 02-09-23
Director/Board Member 73 13-01-28
Director/Board Member 69 10-07-25
More insiders
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
232 USD
Average target price
278.7 USD
Spread / Average Target
+20.14%
Consensus